BIORQ — Biora Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $35.40m
- $0.00m
Biora Therapeutics falls on reverse stock split plan
Brief: Biora Therapeutics Announces Reverse Stock Split
Brief: Biora Therapeutics Inc - On December 6, Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq - Filing
Brief: Biora Therapeutics Licenses Preeclampsia Rule-Out Test For Commercial Development
Biora Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update, Reports Third Quarter 2022 Financial Results
Biora Therapeutics Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: Biora Therapeutics Announces $9.75 Million Direct Offering
Biora Therapeutics Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: Biora Therapeutics Announces Sale Of Cell-Free DNA Patent Rights
Brief: Biora Therapeutics Shares Data From Device Performance Study In Ulcerative Colitis Patients
Brief: Biora Therapeutics Appoints Dr. Bruce Sands As Chair Of Its Clinical Advisory Board
Biora Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Biora Therapeutics Reports Second Quarter 2022 Financial Results
Biora Therapeutics Inc expected to post a loss of 12 cents a share - Earnings Preview
Biora soars as drug delivery device shows promise in colitis study
Brief: Biora Therapeutics Announces Successful Completion Of Device Performance Study In Ulcerative Colitis Patients For Its Targeted Therapeutics Platform
Biora Therapeutics Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Biora Therapeutics Announces Five Abstracts Accepted At American College Of Gastroenterology Annual Scientific Meeting 2022